Robbins LLP reminds stockholders that a class action has been filed on behalf of investors who purchased Embecta Corp. securities between November 25, 2025 and May 4, 2026. The lawsuit alleges that Embecta misled investors by providing overly optimistic guidance for fiscal year 2026, particularly regarding its pen needle segment. On May 5, 2026, the company reported it missed second-quarter guidance, lowered full-year guidance by 46%, and cut its dividend by 93%, causing its stock price to drop over 57% to $3.90 per share. Shareholders who wish to serve as lead plaintiff must file papers by August 17, 2026.
Embecta CorpLawsuit alleges misleading guidance; company missed guidance, cut guidance by 46%, and slashed dividend by 93%, causing stock to drop 57%.